SCHEMBL16204243

SCHEMBL16204243

C=CC[C@H](N)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26537599 1.00
Acetic Acid SCHEMBL31261309 0.81 GRIK1 (0.59)
SCHEMBL14227026 0.79 GRIK1 (0.41)
SCHEMBL28130572 0.79
SCHEMBL14227024 0.79 GRIK1 (0.41)
SCHEMBL24296090 0.79 GRIK1 (0.41)
SCHEMBL1045132 0.77
SCHEMBL616036 0.77
SCHEMBL44428 0.77
SCHEMBL4619445 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365556-A1 N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE PLIANT THERAPEUTICS, INC. (US) 2023-11-16 US disclosed
US-20230242491-A1 DIMERS FROM BIOREACHABLE MOLECULES AS COPOLYMERS ZYMERGEN INC. (US) 2023-08-03 US disclosed
US-11673887-B2 N-acyl amino acid compounds and methods of use PLIANT THERAPEUTICS, INC. (US) 2023-06-13 US disclosed
US-20140322302-A1 THERAPEUTIC PEPTIDES COMBIMAB, INC (US) 2014-10-30 US disclosed